Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Share News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Ceiba Investme. News

EXECUTIVE CHANGES: Ryanair taps Kingspan CFO; new Informa non-execs
1 Oct 2021

EXECUTIVE CHANGES: Ryanair taps Kingspan CFO; new Informa non-execs

EXECUTIVE CHANGES: Ryanair taps Kingspan CFO; new Informa non-execs

EARNINGS UPDATES: Digitalbox swings to profit; Itaconix revenue up 26%
28 Sep 2021

EARNINGS UPDATES: Digitalbox swings to profit; Itaconix revenue up 26%

EARNINGS UPDATES: Digitalbox swings to profit; Itaconix revenue up 26%

TRADING UPDATES: LSL Property profit surges despite lower revenue
28 Apr 2021

TRADING UPDATES: LSL Property profit surges despite lower revenue

TRADING UPDATES: LSL Property profit surges despite lower revenue

TRADING UPDATES: Distil expects solid annual growth, revenue up 48%
14 Apr 2021

TRADING UPDATES: Distil expects solid annual growth, revenue up 48%

TRADING UPDATES: Distil expects solid annual growth, revenue up 48%

IN BRIEF: Ceiba Investments Expects Rise in Income In 2020
16 Dec 2020

IN BRIEF: Ceiba Investments Expects Rise in Income In 2020

IN BRIEF: Ceiba Investments Expects Rise in Income In 2020

UK Shareholder Meetings Calendar - Next 7 Days
26 Nov 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

UK EARNINGS SUMMARY: Trans-Siberian Profit Down On Covid-Related Costs
29 Sep 2020

UK EARNINGS SUMMARY: Trans-Siberian Profit Down On Covid-Related Costs

UK EARNINGS SUMMARY: Trans-Siberian Profit Down On Covid-Related Costs

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine
8 Jun 2020

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine